explore -WSS

explore

author：explore 2025-10-02 20:49:11 - browse：72126

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

WSS

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

IVF, abortion rights issues kick off Biden’s State of the Union

General Catalyst, Summa Health deal will turn on physician buy

Even great ERs can’t make up for American health disparities

How to bring more disabled researchers into academia

CDC marks new Covid

focus

explore

leisure time

Walensky prepares to leave CDC — and Congress — behind

Cybersecurity threat forces Lurie Children's to take systems offline

Psychedelics group wrestles with new pharma identity

Novo Nordisk obesity pill bests Wegovy in early trial

Novavax promises a turnaround & Lilly roils the obesity market

Covid misinformation case heads to Supreme Court

Anesthesiologist group: stop taking Ozempic before surgery

Biden administration opens offers in Medicare drug price negotiations

What does generative AI mean for health care? We asked experts

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

entertainment

What it’s like to watch children die of measles

RSV shot was 90% effective at preventing hospitalizations in kids

CDC marks new Covid

Headspace, Meta partner to launch VR meditation app for Quest

Commercial surrogacy can be ethical, despite pope’s claims

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

hotspot

entertainment

leisure time

Wikipedia